Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma

PURPOSE: Objective responses are reported in 34% to 37% of patients with programmed death-1 (PD-1)–naïve advanced melanoma treated with PD-1 inhibitors. Pre-existing CD8+ T-cell infiltrate and interferon (IFN) gene signature correlate with response to PD-1 blockade. Here, we report a phase Ib/II stu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Davar, Diwakar, Wang, Hong, Chauvin, Joe-Marc, Pagliano, Ornella, Fourcade, Julien J., Ka, Mignane, Menna, Carmine, Rose, Amy, Sander, Cindy, Borhani, Amir A., Karunamurthy, Arivarasan, Tarhini, Ahmad A., Tawbi, Hussein A., Zhao, Qing, Moreno, Blanca H., Ebbinghaus, Scott, Ibrahim, Nageatte, Kirkwood, John M., Zarour, Hassane M.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2018
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286160/
https://ncbi.nlm.nih.gov/pubmed/30359157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00632
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares